TREVOL validates mixed reality in real clinical environments

The Miguel de Cervantes European University (UEMC) from Valladolid, together with the entities that make up the consortium, The TREVOL project has successfully concluded, an applied research initiative that has validated the clinical effectiveness of mixed reality for volumetric assessment of the arm in women with breast cancer.

The project, developed in collaboration with Cluster Innovative Solutions for Independent Living (GRAY), Fenix Physiotherapy e It drives me, and financed through support for innovative business groups (AAEEII) of the Ministry of Economy and Finance of the Government of Castilla y León, co-financed by the European Regional Development Fund with the aim of Achieve a more competitive and intelligent Europe, born to respond to a relevant clinical need: follow-up of lymphedema secondary to breast cancer, one of the most frequent sequelae after oncological treatment and that can significantly affect the functionality and quality of life of patients.

Under the acronym TREVOL (Mixed Reality Technology for Volumetric Evaluation of the Arm in Women with Breast Cancer), The research raised a key question: determine if virtual reality is comparable to the traditional volume estimation method used in consultation, based on tape measure measurements. The results have been conclusive. No significant differences have been observed between both methodologies in the global quantification of arm volume., confirming that the mixed reality tool provides an objective and accurate measurement, comparable to conventional systems.

Mixed Reality, reliable tool

In addition, The study analyzed the ability of both techniques to detect volumetric variations between different clinical visits. Again, The data showed that mixed reality presents the same sensitivity as the traditional method, which reinforces its reliability as an evolutionary monitoring tool in patients at risk or presence of lymphedema..

Beyond technical validation, The research has addressed the feasibility of integrating this technology into real clinical settings, evaluating aspects such as ease of use by healthcare professionals, compatibility with hospital systems, security in data storage and the design of accessible interfaces. The portability and scalability of the system are emerging as determining factors for its future implementation in different healthcare contexts..

With these results, TREVOL consolidates the mixed reality as an innovative alternative y clinically reliable in the follow-up of lymphedema associated with breast cancer, opening new possibilities for the incorporation of immersive technologies in healthcare practice and placing the UEMC at the forefront of applied research in digital health.